메뉴 건너뛰기




Volumn 91, Issue 6, 2007, Pages 843-844

Abducens palsy and Sjögren's syndrome induced by pegylated interferon therapy [8]

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PEGINTERFERON; ALPHA2A INTERFERON; ANTINEOPLASTIC AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2A; PEGINTERFERON ALPHA2A; UNCLASSIFIED DRUG;

EID: 34249791176     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.110494     Document Type: Letter
Times cited : (12)

References (8)
  • 2
    • 28844488786 scopus 로고    scopus 로고
    • Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis
    • d'Alteroche L, Majzoub S, Lecuyer Al, et al. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis. J Hepatol 2006;44:56-61.
    • (2006) J Hepatol , vol.44 , pp. 56-61
    • d'Alteroche, L.1    Majzoub, S.2    Lecuyer, A.3
  • 3
    • 0036092482 scopus 로고    scopus 로고
    • Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group
    • Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
    • (2002) Ann Rheum Dis , vol.61 , pp. 554-558
    • Vitali, C.1    Bombardieri, S.2    Jonsson, R.3
  • 4
    • 0028125161 scopus 로고
    • Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C
    • Fukumoto Y, Shigemitsu T, Kajii N, et al. Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C. Intern Med 1994;33:637-40.
    • (1994) Intern Med , vol.33 , pp. 637-640
    • Fukumoto, Y.1    Shigemitsu, T.2    Kajii, N.3
  • 5
    • 0030825604 scopus 로고    scopus 로고
    • Abducens nerve palsy in a case under treatment with systemic interferon
    • Hosogi M, Hasebe S, Matsuo T, et al. Abducens nerve palsy in a case under treatment with systemic interferon. Rinsho Ganka 1997;51:1357-60.
    • (1997) Rinsho Ganka , vol.51 , pp. 1357-1360
    • Hosogi, M.1    Hasebe, S.2    Matsuo, T.3
  • 6
    • 0035067470 scopus 로고    scopus 로고
    • Abducens nerve enhancement demonstrated by multiplanar reconstruction of contrast-enhanced three-dimensional MRI
    • Hosoya T, Adachi M, Yamaguchi K, et al. Abducens nerve enhancement demonstrated by multiplanar reconstruction of contrast-enhanced three-dimensional MRI. Neuroradiology 2001;43:295-301.
    • (2001) Neuroradiology , vol.43 , pp. 295-301
    • Hosoya, T.1    Adachi, M.2    Yamaguchi, K.3
  • 7
    • 0033150068 scopus 로고    scopus 로고
    • Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis
    • Dumoulin FL, Leifeld L, Sauerbruch T, et al. Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis. Biomed Pharmacother 1999;53:242-54.
    • (1999) Biomed Pharmacother , vol.53 , pp. 242-254
    • Dumoulin, F.L.1    Leifeld, L.2    Sauerbruch, T.3
  • 8
    • 27344449474 scopus 로고    scopus 로고
    • Retinopathy is not the only ocular symptom: Myasthenia gravis in association with interferon therapy
    • Oishi A, Miyamoto K, Kashii S, et al. Retinopathy is not the only ocular symptom: myasthenia gravis in association with interferon therapy. Br J Ophthalmol 2005;89:1542-3.
    • (2005) Br J Ophthalmol , vol.89 , pp. 1542-1543
    • Oishi, A.1    Miyamoto, K.2    Kashii, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.